NOAH attends its first international regulatory VICH meeting
NOAH is pleased to have been invited to attend the 39th meeting of the VICH (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products). Joining as a guest alongside the VMD, this marked a significant step as the transition period for the UK to leave the EU comes to an end.
VICH promotes the establishment of safe and effective veterinary medicinal products across the world through wider international harmonisation of technical requirements for the registration of veterinary medicinal products. Now in its third decade of activity, the 39th VICH Steering Committee and 13th VICH Outreach Forum (VOF) annual meetings took place on-line from 16 to 19 November 2020.
Until now, the UK has been a part of the EU team, represented through the European Medicines Agency (EMA) and AnimalHealthEurope, the European animal health association.
Dawn Howard, NOAH chief executive commented: “Whilst NOAH remains an active member of AnimalHealthEurope, the UK Veterinary Medicines Regulations, which have been linked to the EU regulatory process for many years, will be independent from January 2021. We look forward to working jointly with VMD to represent UK within VICH.
“It is very welcome to be involved in these global discussions to be able to share expertise and reach global consensus on how animal medicines are regulated,” she said.
Notes for Editors
For more information please contact Dawn Howard or Alison Glennon at NOAH on 020 8367 3131 or see www.noah.co.uk
NOAH represents the UK animal health industry. Its aim is to promote the benefits of safe, effective, quality products and services for the health and welfare of all animals.
For more about the VICH see https://www.vichsec.org/en/about/what-is-vich.html